"Dr. Karen Harkaway is a board-certified dermatologist at Schweiger Dermatology Group. She graduated with a Bachelor of Science degree with Honors from Duke University, where she was elected to the Phi Beta Kappa honor society. Dr. Harkaway completed her medical degree at the University of Pennsylvania and was elected to the medical honor society, Alpha Omega Alpha. Dr. Harkaway remained at the Hospital of the University of Pennsylvania for her internship and residency training in dermatology. Since then, she has been in private practice and serves as Chief of Dermatology at Lourdes Medical Center of Burlington. Dr. Harkaway has an extensive background in cosmetic dermatology and dermatologic surgery."

During the past decade, Karen S. Harkaway, MD, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Karen S. Harkaway, MD, LLC" are "Actinic Keratosis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Karen S. Harkaway, MD, LLC" in a lesser frequency.

Most popular intervention types in "Karen S. Harkaway, MD, LLC" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PEP005 Topical gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karen S. Harkaway, MD, LLC" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Karen S. Harkaway, MD, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Karen S. Harkaway, MD, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karen S. Harkaway, MD, LLC, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".